ABSTRACT
INTRODUCTION
Asthma is an inflammatory disorder of the airways characterized by reversible airway obstruction and bronchial hyper-responsiveness. Although environmental factors are important determinants of asthma, numerous studies have revealed that asthma has a strong genetic component.
1
Clara cell 10-kDa protein (CC10, also known as CC16, SCGB1A1, uteroglobin) is a 10-kDa protein produced by non-ciliated Clara cells and is one of the most abundant proteins in the fluids lining the airways. 2 The CC10 gene is located on chromosome 11q12-13, a region that has been associated with asthma and atopy in several genome-wide linkage studies. 3, 4 A single nucleotide polymorphism, the +38A/G polymorphism (rs3741240), has been identified in this gene. 5 Some papers have reported that this polymorphism was associated with asthma risk, whereas others found no such association. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] It was possible that most of these studies only included a modest sample size, and thus each of them might not achieve a reliable conclusion. Meta-analysis is a useful method for investigating associations between genetic factors and diseases, www.pjms.com.pk because a quantitative approach is used to combine the results from different studies on the same topic, thereby providing more reliable conclusions.
15
Here, we use meta-analysis to clarify the association of CC10 +38A/G polymorphism with asthma. To our knowledge, this is the first genetic metaanalysis of the association between CC10 +38A/G polymorphism and the risk of asthma.
METHODS

Search for publications:
We performed a literature search using the MEDLINE and China National Knowledge Infrastructure (CNKI) databases to identify articles that examined associations between CC10 +38A/G polymorphism and asthma. The following key words and subject terms were searched: Clara cell 10-kDa protein, CC10, CC16, SCGB1A1, uteroglobin, asthma, genetic, and polymorphism. Reference lists of articles retained for review were inspected for relevant publications. No publication date or language restrictions were imposed. Inclusion and exclusion criteria: The following inclusion criteria were used: (i) the study should have evaluated the association between the +38A/G polymorphism and asthma risk; (ii) the study should have had a case-control design; (iii) sufficient data should have been provided in order to calculate odds ratios (OR) and 95% confidence intervals (CI). Studies were excluded if any of the following conditions applied: (i) only abstracts or reviews were available, without sufficient data; (ii) genotype frequencies were not reported; (iii) studies were repeated or publications overlapped. Data extraction: The following information was extracted from each study: author, year of publication, ethnicity of the study population, numbers of cases and controls, and CC10 +38A/G genotype numbers.
Statistical analysis:
Meta-analyses were performed using dominant model (AA + AG vs GG). Heterogeneity among studies was assessed using the chi-square based Q and I 2 statistics. Heterogeneity was considered to be significant for I 2 > 50%. Fixed-effects or random-effects models were used to pool the data according to heterogeneity. Other comparative genetic models were also used to assess the association between the polymorphism and the risk of asthma (AA vs AG + GG, AA vs GG, AG vs GG, and A vs G). For the subgroup analysis by ethnicity, the study populations were stratified into two groups: Asian and Caucasian. Galbraith plot was used to spot the outliers which were the sources of heterogeneity. Funnel plot and Egger's test were used to detect publication bias.
16 Analyses were performed using Revman 5.1 and STATA 11.0 software.
RESULTS
Characteristics of studies:
A total of 10 relevant articles on CC10 +38A/G polymorphism in asthma met the study inclusion criteria (Table-I) , and were included in the meta-analysis. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Finally, 1529 genotyped asthma cases and 2399 genotyped non-asthmatic controls were included in the metaanalysis. Five case-control studies were performed in Asian populations; while five were performed in Caucasian populations. The characteristics of each case-control study and the genotype and allele distributions in each case-control study are presented in Table-I . Results of meta-analyses: As shown in Fig.1 , the heterogeneity of AA + AG vs GG was assessed for all 10 studies, and the chi-square value was 26.07 with 9 degrees of freedom and P = 0.002 in a randomeffects model. Therefore, a random-effects model was used for synthesis of the data. The overall OR was 1.62 (95% CI, 1.23-2.12), and the Z-test value for overall effect was 3.47 (P = 0.0005) for the AA + AG vs GG. Subgroup analysis by ethnicity was performed. For ethnicity, the populations were stratified into two groups: Asian (908 cases and 784 controls), Caucasian (621 cases and 1615 controls). There were significant associations with asthma risk in these populations: Asian (OR = 1.87; 95% CI, 1.20-2.91; P = 0.005) and Caucasian (OR = 1.41; 95% CI, 1.02-1.94; P = 0.04). Publication bias was assessed graphically by using funnel plots and assessed statistically by using Egger's test. The shape of the Begg's funnel plots appeared symmetrical for the AA + AG vs GG model (Fig.2 ). Egger's test was performed to provide statistical evidence of funnel plot asymmetry (P = 0.99). Summary results from the other comparisons are presented in Table- II.
Heterogeneity analysis:
The between-study heterogeneity was obvious in dominant model (I 2 = 65%). Galbraith plots spotted Sharma's study and Chen's study as the outliers and the major source of the heterogeneity (Fig.3) . The heterogeneity remarkably decreased in dominant model after excluding Sharma's study and Chen's study (I 2 = 43%). Besides, a significant association was also observed after excluding Sharma's study and Chen's study (OR = 1.63; 95% CI, 1.26-2.11; P = 0.0002).
DISCUSSION
CC10 with primary expression in the uterus and non-ciliated bronchiolar cells, has an antiinflammatory effect on the urogenital and respiratory tracts. 17, 18 Deficiency of CC10 aggravates pulmonary allergic inflammation through augmentation of the TH2 response, and reconstitution of CC10 in CC10-deficient mice is able to reverse the altered phenotypes. 19 These results suggested that CC10 played an important role in the development of asthma. Although asthma can have many causes, genetic factors are considered strong determinants, and therefore, researchers have searched for the genes responsible. Several studies have investigated the role of CC10 +38A/G polymorphism in asthma susceptibility both in Asians and Caucasians, with contrasting results. Meta-analysis has been recognized as an important tool to more precisely define the effect of selected genetic polymorphisms on risk of disease. Therefore, we performed the meta-analysis specifically to assess this association. The present meta-analysis found a significant association between the CC10 +38A/G polymorphism and asthma risk (OR = 1.62; 95% CI, 1.23-2.12; P = 0.0005). In addition, subgroup analysis by ethnicity showed that this polymorphism was significantly associated with increased asthma risk in both the Caucasians (OR = 1.41; 95% CI, 1.02-1.94; P = 0.04) and Asians (OR = 1.87; 95% CI, 1.20-2.91; P = 0.005). Moreover, other genetic models also found positive results. Thus, meta-analysis of available data suggests CC10 +38A allele contributes to increased asthma risk.
The importance of heterogeneity should be mentioned, as it is an important issue when interpreting the results of meta-analyses. In this present meta-analysis, we found obvious heterogeneity (I 2 = 65%). Galbraith plot was used to spot the outliers as the possible major sources of heterogeneity. Two studies were spotted as the outliers. After excluding those two studies, the between-study heterogeneity decreased and there was no obvious heterogeneity among the left 8 studies (I 2 = 43%), which suggested the heterogeneity might come from those two studies. Meta-analysis of the left 8 studies also showed CC10 +38A/G polymorphism was associated with increased risk of asthma (OR = 1.63; 95% CI,1.26-2.11; P = 0.0002).
Some possible limitations in this meta-analysis should be acknowledged. First, only published studies that were included in the selected electronic databases were identified; it is possible that some relevant published or unpublished studies that supported the null hypothesis may have been missed, which may have biased the results, and this may not have been detected by the statistical tests that were performed. Second, the effect of gene-gene and gene-envi ronment interactions was not addressed in this meta-analysis status, because of limited available data. Third, all the data were used without adjustment by detailed individual information such as age, sex, and lifestyle in our meta-analysis. Finally, the number of included studies was moderate.
To sum up, this meta-analysis suggests that CC10 +38A/G polymorphism confers asthma risk. Further studies can assess the possible geneenvironmental and gene-gene interactions in the association between this polymorphism and asthma risk. 
